
Keywords: Retinal remodeling; Neurodegeneration; Glial cells; Retinal therapy; Neuroprotection; Retinal diseasesAAV, Adeno-associated virus; AGEs, Advanced glycation end products; AMD, Age-related macular degeneration; Apaf-1, Apoptotic protease-activating factor-1